Form 253G1 -
SEC Accession No. 0001104659-20-136485
Filing Date
2020-12-17
Accepted
2020-12-16 21:15:22
Documents
2

Document Format Files

Seq Description Document Type Size
1 253G1 tm2024664-15_253g1.htm 253G1 2000972
2 GRAPHIC lg_scopus-pn.jpg GRAPHIC 2106973
  Complete submission text file 0001104659-20-136485.txt   4387980
Mailing Address 420 LEXINGTON AVENUE, SUITE 300 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE, SUITE 300 NEW YORK NY 10170 (212) 479-2513
Scopus BioPharma Inc. (Filer) CIK: 0001772028 (see all company filings)

IRS No.: 821248020 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 253G1 | Act: 33 | File No.: 024-11228 | Film No.: 201394048
SIC: 2834 Pharmaceutical Preparations